Johan Levy

Papers

Total Citations

H-Index

About

Johan Levy is a radiation oncologist whose work centers on advancing stereotactic radiotherapy techniques for early-stage breast cancer. His most notable contribution is the phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer," which explored the feasibility and safety of delivering a precise, high-dose radiation boost using robotic stereotactic radiosurgery following whole-breast irradiation. This study, published in 2018, demonstrated promising local control rates with minimal toxicity, offering a refined alternative to conventional boost methods. While the paper has accrued 3 citations to date, its significance lies in pioneering a more targeted approach that reduces treatment duration and spares healthy tissue. Levy’s research sits at the intersection of technological innovation and clinical pragmatism, aiming to improve patient outcomes through dose escalation and precision. His work contributes to the broader shift toward hypofractionation and stereotactic body radiotherapy in breast cancer management, a field where even modest citation counts can reflect early-stage, high-impact ideas. For students and researchers, Levy exemplifies how focused, hypothesis-driven trials can push the boundaries of radiation oncology, blending robotics with patient-centered care.